Logo image
IRO Home Research units Researcher Profiles
Sign in
Lower motor neuron disease in a patient with autoantibodies against Gal(beta 1-3)GalNAc in gangliosides GM1 and GD1b: improvement following immunotherapy
Journal article   Peer reviewed

Lower motor neuron disease in a patient with autoantibodies against Gal(beta 1-3)GalNAc in gangliosides GM1 and GD1b: improvement following immunotherapy

M E Shy, T Heiman-Patterson, G J Parry, A Tahmoush, V A Evans and P K Schick
Neurology, Vol.40(5), pp.842-844
05/1990
DOI: 10.1212/WNL.40.5.842
PMID: 2330115

View Online

Abstract

We followed a patient with a lower motor neuron form of motor neuron disease whose neurologic disorder improved following immunotherapy. The patient did not have an M protein but did have IgM antibodies to ganglioside GM1 detectable at serum titers of 1:2,000 by ELISA. These antibodies were found only in the IgM fraction with lambda light chains and immunoreacted with GD1b and Gal (beta 1-3) GalNAc.
Neuromuscular Diseases - immunology Chromatography, High Pressure Liquid - methods Enzyme-Linked Immunosorbent Assay Motor Neurons - immunology Humans Immunoglobulin M - analysis Male Gangliosides - immunology Neuromuscular Diseases - therapy Disaccharides - immunology G(M1) Ganglioside - immunology Immunotherapy Adult Antigens, Tumor-Associated, Carbohydrate Autoantibodies - analysis

Details

Metrics

Logo image